Overview

Optimal Treatment of MRSA Throat Carriers

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the optimal way to treat MRSA throat carriers.
Phase:
Phase 3
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Clindamycin
Clindamycin palmitate
Clindamycin phosphate